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Abstract
Replication of arboviruses in their arthropod vectors is controlled by innate immune responses. The RNA sequence-specific
break down mechanism, RNA interference (RNAi), has been shown to be an important innate antiviral response in
mosquitoes. In addition, immune signaling pathways have been reported to mediate arbovirus infections in mosquitoes;
namely the JAK/STAT, immune deficiency (IMD) and Toll pathways. Very little is known about these pathways in response to
chikungunya virus (CHIKV) infection, a mosquito-borne alphavirus (Togaviridae) transmitted by aedine species to humans
resulting in a febrile and arthralgic disease. In this study, the contribution of several innate immune responses to control
CHIKV replication was investigated. In vitro experiments identified the RNAi pathway as a key antiviral pathway. CHIKV was
shown to repress the activity of the Toll signaling pathway in vitro but neither JAK/STAT, IMD nor Toll pathways were found
to mediate antiviral activities. In vivo data further confirmed our in vitro identification of the vital role of RNAi in antiviral
defence. Taken together these results indicate a complex interaction between CHIKV replication and mosquito innate
immune responses and demonstrate similarities as well as differences in the control of alphaviruses and other arboviruses
by mosquito immune pathways.
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Introduction
Arthropod-borne viruses (arboviruses) replicate in both their
vertebrate host and arthropod vector. This poses a unique
problem for arboviruses as they are exposed to both the vertebrate
and invertebrate immune systems. Arthropod vectors of arbovi-
ruses, such as mosquitoes, do not have the combination of innate
and adaptive immune systems of vertebrates and must therefore
rely on the innate immune system to control arbovirus replication.
When the mosquito vector ingests a blood-meal from a viraemic
vertebrate host, arboviruses infect the midgut epithelial cells.
Successful replication and passage through the midgut allows the
virus to disseminate into the hemocoel and infect other tissues such
as the trachea, fat body, and salivary glands. Once the virus is
detected in saliva, the mosquito becomes competent for transmis-
sion to the next vertebrate host [1,2]. Therefore, interactions
between the replicating virus and the mosquito immune defence
system produce an outcome that can influence subsequent viral
transmission, as shown for the flavivirus dengue (DENV) [3]. This
emphasizes the importance of further understanding innate
immunity in arbovirus vectors.
Several innate immune responses have been reported to have an
antiviral effect in mosquitoes, and these include RNA interference
(RNAi), as well as responses mediated by Toll, Immune Deficiency
(IMD) and JAK/STAT signaling pathways [4–6]. The exogenous
(antiviral) RNAi pathway is induced by the presence of long
double-stranded RNA (dsRNA) molecules, which in the case of
RNA viruses may arise from secondary RNA structures in the viral
genome, the viral genome itself (in case of dsRNA viruses) and/or
viral replication intermediates. Much of our understanding of
arthropod RNAi is based on research on Drosophila melanogaster,
which has also proved very useful in providing insights into
antiviral responses in mosquitoes [7]. In the exogenous RNAi
pathway, these dsRNAs are recognized by the RNAse III enzyme
Dicer 2 (Dcr-2) [8] and cleaved into 21 nt small interfering RNA
(siRNA) also known as virus induced small interfering RNAs
(viRNAs) [9–15], a hallmark of RNAi induction. The siRNAs/
viRNAs are loaded into the multi-protein RNA Induced Silencing
Complex (RISC), of which the core catalytic component is the
endonuclease Argonaute-2 (Ago-2) [16]. Ago-2 unwinds the
siRNAs/viRNAs and retains one strand (guide strand) to recognize
single-stranded (viral) complementary sequence such as genomic
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RNA or mRNA, which triggers the endonucleic cleavage of the
complementary RNA by Ago-2 [17]. A key role for mosquito Ago-
2 and Dcr-2 in antiviral responses has also been demonstrated
experimentally [18,19]. Sequence specific degradation of RNA
results in repression of virus replication and virus production.
Similarly, Toll, IMD and JAK/STAT signaling pathways have
been described in Drosophila with pathway homologues also
identified in mosquitoes. In the mosquito Aedes aegypti, the Toll
and JAK/STAT signaling pathways have been shown to induce
antiviral activities targeting DENV [20,21]. In culicine mosqui-
toes, West Nile virus (WNV) (Flaviviridae) was also shown to be
inhibited by the JAK/STAT pathway and that this response is
thought to be controlled by the cytokine Vago [22]. In the case of
alphaviruses of the Togaviridae family, such as Sindbis virus
(SINV) or Semliki Forest virus (SFV), the data are less clear. At
least in mosquito cells, antiviral activity against SFV was shown to
be mediated by either IMD or JAK/STAT pathways following
bacterial stimulation [23]. Recent research in Drosophila further
implies those pathways in control of SINV infection [24,25]
although no upregulation of target genes was shown in Ae. aegypti-
derived Aag2 cells [26]. However, in the case of Anopheles
gambiae infection by the alphavirus o’nyong-nyong (ONNV), the
contribution of the IMD pathway is only minor [27]. These
pathways may therefore act in a virus-specific manner. In contrast
to vertebrate cells where viral inhibition of innate immunity is an
area of intense research, similar processes in arbovirus/vector
interactions are poorly understood. Several arboviruses have
previously been shown to inhibit or evade the antiviral action of
these host responses in mosquitoes. An RNAi evasion strategy has
been suggested for SFV, while flavivirus subgenomic RNA acts as
an RNAi inhibitor [11,28]. Inhibition of immune signaling
pathways such as JAK/STAT, Toll and IMD has been described
for SFV [23], while DENV has been shown to interfere with Toll
and IMD signaling [29]. This suggests further complexity in
arbovirus/vector interactions and the relevance of this is only just
emerging, and needs to be assessed for each virus family and even
each virus individually.
Chikungunya virus (CHIKV) belongs to the genus Alphavirus
of the family Togaviridae. It has become an increasingly important
arbovirus in tropical and subtropical regions, resulting in febrile
and arthralgic disease in humans [30]. After the large outbreak in
the Indian Ocean in 2004, CHIKV infections have spread
throughout the Indian Ocean and Africa into Southern Europe
[31]. Moreover, the virus has emerged for the first time in the
Americas (St. Martin/Martinique, Caribbean) in December 2013,
thus potentially threatening other parts of the New World (see
WHO Website for information). CHIKV is spread by aedine
mosquitoes with Ae. aegypti being the most important vector and
more recently Ae. albopictus following changes in the E1 envelope
protein [32,33]. The viral genome is a single stranded positive
sense RNA containing two open reading frames: one expressing
the non-structural polyprotein which will be cleaved into non-
structural viral proteins (nsP1-4), and one structural polyprotein
which will be cleaved into the structural proteins. The mRNA
encoding the structural polyprotein is transcribed from the
subgenomic promoter during virus replication. Little is known
about innate immune responses induced by CHIKV during
infection of mosquitoes. Identification of small RNAs derived from
CHIKV in aedine mosquitoes and their derived cell lines proves
the ability of the RNAi pathway to target CHIKV. Moreover,
21 nt viRNAs as well as another class of virus-derived small RNAs
with characteristics of Piwi-interacting RNAs (piRNAs) were
discovered [12]. However, nothing is known about the functional
ability of this RNAi response to limit CHIKV replication in
mosquito cells or mosquitoes, or the involvement of other innate
immune responses.
In this study, we investigated the major antiviral Ae. aegypti
immune pathways and assayed their ability to control CHIKV
replication in cell culture, where experimental conditions are easily
controlled and manipulated. The exogenous RNAi pathway was
identified as a key control mechanism of CHIKV replication and
this was further confirmed in mosquitoes. Moreover, CHIKV
repressed Toll, IMD and JAK/STAT pathway stimulation in vitro
by induction of host cell shut off and none of the pathways were
able to mediate antiviral responses against CHIKV replication.
These data indicate the importance of RNAi as a mosquito
antiviral response also targeting CHIKV replication as well a
complex interplay with other host responses.
Methods
Viruses and cell culture
CHIKV E1-226V strain (provided by the French National
Reference Center for Arboviruses, Institut Pasteur) was used for
mosquito infections. The strain was isolated from a patient on La
Reunion Island in November 2005 as part of a survey during an
outbreak, as described in [34].
Vero cells were cultured in DMEM (Dulbecco’s Modified Eagle
Medium) supplemented with 10% fetal bovine serum (FBS), 1000
units/ml penicillin, 1 mg/ml streptomycin, and maintained at
37uC and 5% CO2. Ae. aegypti Aag2 and Ae. albopictus C6/36
cells (for virus propagation) were grown in Leibovitz L-15 insect
medium with 10% FBS, 10% tryptose phosphate broth, 1000
units/ml penicillin, and 1 mg/ml streptomycin at 28uC.
For CHIKV titer determination, Vero cells were grown to
confluent monolayers in 6-well plates, infected with 10-fold serial
dilutions of virus for 1 h, and then overlaid with an agarose-
nutrient mixture. After 3 days incubation at 37uC, cells were
stained with a solution of crystal violet (0.2% in 10% formaldehyde
and 20% ethanol). The total number of plaques was counted and
the titer was calculated. Titers are indicated as plaque forming
units (PFU)/ml.
Plasmids and CHIKV-derived replicons
Use of plasmids pAct-Renilla (coding sequence of Renilla
luciferase (RLuc) under control of the Drosophila actin 5C
Author Summary
Chikungunya virus (CHIKV) is a mosquito-borne human-
pathogenic arbovirus of the Togaviridae family, genus
Alphavirus. Arbovirus replication in vectors, such as
mosquitoes, is not passively tolerated but leads to immune
responses, that control virus infection. These responses
therefore represent interesting targets for novel interven-
tion strategies. Mosquito antiviral immune responses, such
as small RNA pathways or immune signaling pathways, are
increasingly well studied but it is not known which one
mediate antiviral effects against CHIKV in particular. Here
we screened four key immune responses in vitro for their
antiviral potential against CHIKV and only the exogenous
RNA interference was found to mediate antiviral activity.
This was confirmed in vivo in Aedes aegypti mosquitoes.
Immune signaling pathways were not found to mediate
antiviral activity but were inhibited by CHIKV. This shows
interesting differences and similarities to other mosquito-
borne alphaviruses that increase our understanding of
alphavirus-mosquito interactions.
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promoter), p662DRAF-Luc (coding sequence of firefly luciferase
(FFLuc) under control of a multimerised Drosophila STAT-
responsive element), pJL195 (coding sequence of FFLuc under
control of the Drosophila attacin A promoter) and pJM648 (coding
sequence of FFLuc under control of the Drosophila drosomycin
promoter) in signaling pathway experiments have been previously
described [23]. Luciferase SP6 Control DNA plasmid (Promega)
expressing FFLuc under control of SP6 promoter was used as a
template for in vitro transcription of a control RNA.
Nonstructural open reading frame of CHIKVRep(3F)RLuc-
SG-FFLuc replicon contains RLuc encoding sequence inserted
between codons for amino acid residues 383 and 384 of CHIKV
nsP3. In place of the structural open reading frame, mRNA
encoding for FFLuc is transcribed following replication by use of
the subgenomic promoter. Replicon CHIKVRep-SG-eGFP con-
tains the nonstructural open reading frame without any reporter
genes and mRNA of eGFP is transcribed following replication by
use of the subgenomic promoter.
In vitro transcription
Replicon DNA was linearized by digestion with NotI, purified
using a PCR purification kit (Roche) and 1 mg of the linearized
DNA was in vitro transcribed using MEGAscript SP6 polymerase
kit (Ambion) in the presence of Cap analog (Ambion). Control
Luciferase SP6 DNA was linearized by digestion with XmnI,
purified by gel extraction and in vitro transcribed as before. For all
subsequent experiments, 2 ml of in vitro transcription was trans-
fected.
dsRNA production for mosquito transfection
Total RNA was extracted from adult Ae. aegypti using the RNA
II Nucleospin kit (Macherey-Nagel GmbH & Co.) according to the
manufacturer’s instructions. cDNAs were generated from 60 ng of
total RNA by reverse transcription using SuperScript II Reverse
Transcriptase (Invitrogen) and oligo dT. To synthesize dsRNA,
cDNA was amplified with gene specific primers (table 1 designated
as being for use in vivo) incorporating the T7 RNA polymerase
promoter sequences (in bold) at the 59 ends. Primers were designed
to amplify a unique ,500 bp region in the PIWI domain for Ago-
2. PCR was carried out using the KOD Hot Start DNA
Polymerase (Novagen). PCR products were purified with the
QIAquick Gel Extraction kit (Qiagen) and dsRNA was produced
using the MEGAscript RNAi kit (Ambion) according to the
manufacturer’s instructions.
dsRNA production for transfection of cultured mosquito
cells
RNA was extracted from Aag2 cells using TRIzol and reverse
transcribed using Superscript III Reverse Transcriptase (In-
vitrogen) following the manufacturer’s instructions. PCR prod-
ucts were generated with T7 promoter sequences at either end
of the fragment using the primers listed in table 1 and
designated as for use in vitro. The PCR product was blunt
end cloned into a pJet1.2 vector (Thermo Scientific) following
the manufacturer’s instructions. Cloned PCR fragments were
verified by sequencing. PCR was performed on the cloned
fragments and the products purified using the PCR purification
kit (Roche). peGFP-C1 (Clontech) was used as a template for the
amplification of control dsRNA, targeting eGFP. dsRNA was
synthesized using the Megascript RNAi kit (Ambion) following
manufacturer’s instructions.
Transfection and signaling pathway stimulation
experiments
24 h prior to transfection, 1.76105 Aag2 cells were seeded in
24-well plates to reach 70% confluence the following day. For
knockdown experiments, 500 ng of dsRNAs were transfected into
Aag2 cells using Opti-MEM and Lipofectamine2000 (Invitrogen)
according to manufacturer’s instructions. At 24 h post dsRNA
transfection, cells were transfected with capped in vitro transcribed
Table 1. Table of all primer sequences.
Primer Sequence 59-39 Use
Ago-1 F GTA ATA CGA CTC ACT ATA GGG ACA GGT TTC ACT GTT CAA CCT dsRNA (in vitro)
Ago-1 R GTA ATA CGA CTC ACT ATA GGG GGT TTG ACC GTT TTC TAG CTG C dsRNA (in vitro)
Ago-2 F GTA ATA CGA CTC ACT ATA GGG GCC CTC AAC AAG AAA CAC C dsRNA (in vitro)
Ago-2 R GTA ATA CGA CTC ACT ATA GGG GGC GTT GAT CTT GAG CCA dsRNA (in vitro)
eGFP F GTA ATA CGA CTC ACT ATA GGG GGC GTG CAG TGC TTC AGC CGC dsRNA (in vitro)
eGFP R GTA ATA CGA CTC ACT ATA GGG GTG GTT GTC GGG CAG CAG CAC dsRNA (in vitro)
Ago-2 F TAA TAC GAC TCA CTA TAG GCA GTT CAA GCA GAC GAA CCA dsRNA (in vivo)
Ago-2 R TAA TAC GAC TCA CTA TAG GTG ATG TAG ACG CGT CCT CTG dsRNA (in vivo)
Luc F TAA TAC GAC TCA CTA TAG GGC GCC CTG GTT CCT GGA AC dsRNA (in vivo)
Luc R TAA TAC GAC TCA CTA TAG GGA GAA TCT CAC GCA GGC AGT TC dsRNA (in vivo)
Ago-2 F GGC TGC TCA CCC AAT GTA TCA AGA qRT-PCR
Ago-2 R AAC CGT TCG TTT TGG CGT TGA T qRT-PCR
Ago-1 F GTA CGA TGC GTC GTA AGT AC qRT-PCR
Ago-1 R GTA CTT GTC GAG GAA GTA TTT GG qRT-PCR
S7 F CCA GGC TAT CCT GGA GTT G qRT-PCR
S7 R GAC GTG CTT GCC GGA GAA C qRT-PCR
All primer sequences are shown reading from 59 to 39. Bases in bold indicate the T7 promoter sequence. The use of each primer pair is also indicated.
doi:10.1371/journal.pntd.0002994.t001
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replicon RNA derived from CHIKVRep(3F)RLuc-SG-FFLuc
using Lipofectamine2000. Cells were lysed in 16 passive lysis
buffer (Promega) 24 h post replicon transfection and luciferase
activities determined.
For the signaling pathway stimulation experiments, bacterial
stocks were prepared by inoculation of 1 ml E. coli JM109 in 5 ml
L-Broth and incubation at 37uC for 16 h or 5 ml B. subtilis
inoculated in 5 ml L-Broth incubated at 37uC for 8 h. E. coli is
used to stimulate the JAK/STAT and IMD pathways and B.
subtilis is used to stimulate the Toll pathway. Cultures were
centrifuged at 1174 g at 4uC for 10 minutes. The bacterial pellet
was then resuspended in 500 ml PBS and heat inactivated at 80uC
for 10 minutes. At 24 h post seeding, Aag2 cells were transfected
with 12.5 ng pAct-Renilla, 25 ng p662DRAF-Luc, 25 ng pJL195
or 500 ng pJM648 and capped in vitro transcribed CHIKV
replicon RNA (derived from CHIKVRep-SG-eGFP) at 24 h post
seeding, using Lipofectamine2000 according to the manufacturer’s
protocol. Cells were stimulated at 24 h post transfection with heat
inactivated E. coli JM109 or B. subtilis for 1 hour at 28uC. 12 h
post stimulation, cells were lysed in 16 passive lysis buffer and
luciferase activities determined.
Mosquitoes and intrathoracic inoculation of dsRNAs
Ae. aegypti Liverpool strain (provided by D. Severson,
University of Notre Dame, IN, USA) were maintained on 10%
sugar solution at 28uC with a photophase of 16 h and 80% relative
humidity according to the standard rearing procedures.
RNAi-based gene-silencing assays were conducted by inject-
ing 500 ng of dsRNA (dsAgo-2 or dsFFLuc) in water into the
thorax of cold-anesthetized 4 day-old females using a Nanoject
II microinjector (Drummond Scientific Company). Blood
feeding was carried out 48 h post dsRNA injection. Gene
silencing validations were performed at day 1, 2, 3, 4 and 7 after
ingestion of the infectious blood-meal. As controls, mosquitoes
injected with PBS and non-injected unfed mosquitoes were
used.
CHIKV infections of mosquitoes
Adult female mosquitoes were deprived of sugar source 24 h
before infection and allowed to feed on artificial blood-meals
consisting of a virus suspension (1/3 vol/vol), washed rabbit
erythrocytes (2/3 vol/vol), and 5 mM ATP. The artificial blood-
meal was provided in glass feeders covered with a chicken skin
membrane and maintained at 37uC. Females placed in plastic
boxes were allowed to feed for 15 minutes. Engorged females were
selected, transferred into cardboard containers, provided with
sugar solution and maintained in BSL-3 insectaries until
analysis. To determine the titer of the infectious blood-meal
which would be used for subsequent RNAi-based gene-silencing
assays, three different virus titers: 106, 107, 108 PFU/ml were
tested. At indicated time points, 10 females were tested for the
presence of CHIKV by immunofluorescence assay (IFA) on
head squashes using mouse ascitic fluid raised against the virus
[35]. Disseminated infection rates (DIR) corresponding to the
number of females with disseminated infection among tested
females, were determined. At various days post infection,
mosquitoes were analyzed as follows: midgut and head were
isolated from each individual and ground in 150 ml DMEM
before being homogenised and filtered. 50 ml of the filtrate was
titrated by plaque assay on Vero cells to estimate the number of
infectious viral particles. The remaining 100 ml was used for
quantification of Ago-2 and ribosomal S7 RNA by real time
quantitative RT-PCR.
Total RNA extraction, real time quantitative RT-PCR, and
PCR
Dissected mosquito organs (midgut and head) were homoge-
nized separately and used for RNA extraction using the
NucleoSpin 96 RNA kit (Macherey-Nagel GmbH & Co). An
equal amount of RNA extracted from each organ was examined
for each time point. Quantification was carried out by real time
quantitative RT-PCR using the Power SYBR Green RNA-to-CT
one step kit (Applied Biosystem).
Total RNA was extracted from cultured cells using TRIzol
(Invitrogen) according to the manufacturer’s instructions. Polyad-
enylated RNAs were reverse transcribed using the Superscript III
kit (Invitrogen) and oligo dT primers (Promega) according to the
manufacturer’s recommendation. Quantification was carried out
by real time quantitative PCR using the Fast SYBR green master
mix (Invitrogen).
All PCR reactions were done in triplicate. Specificity of the
PCR reactions was assessed by analysis of melting curves for each
data point. Values were normalized against the Aedes aegypti
ribosomal protein S7 gene. Following real-time quantitative PCR
assays, analysis of relative expression of Ago-1, Ago-2 and S7 was
performed according to the 22DDCt method [36].
Luciferase assay
Luciferase expression was determined using the Dual Luciferase
kit (Promega). Luciferase activities were determined on a Glomax
Multi+ Microplate Multimode reader (Promega).
Statistical analysis
Virus titer means were compared using the Kruskall-Wallis test
from the STATA software (StataCorp LP). Statistical significance
for replicon replication after knockdown was determined by a
paired Student’s t-test and statistical significance in the stimulation
experiments was determined using a general linear mixed model.
Results
Effects of RNAi effector knockdowns on CHIKV replication
in Aag2 cells
Aag2 cells have proven to be a reliable model for the study of
aedine immune responses including those against viruses given the
presence of all major immune signaling pathways and small RNA
pathways in the cell line [10,11,14,26,29,37]. Not only have
mosquito cell lines been shown to have intact immune pathways
but they also provide a robust system where experiments can be
performed in a controlled manner and have been used extensively
in the mosquito immunity field [10–12,23,29,38–40]. Viral
replicons are useful tools to investigate innate immune responses
in a tightly controlled manner in cell culture experiments. We first
engineered two CHIKV reporter replicons on the basis of the
CHIKV E1-226V strain. The first replicon, named CHIKV-
Rep(3F)RLuc-SG-FFLuc, encodes a non-structural polyprotein
with RLuc inserted into the C-terminal region of nsP3 and mRNA
of FFLuc expressed from the viral subgenomic promoter instead of
the mRNA of structural proteins. A second replicon is expressing
mRNA of eGFP from the viral subgenomic promoter: CHIKV-
Rep-SG-eGFP (Fig. 1A). This replicon was designed with a
fluorescent protein as a reporter rather than luciferase to allow a
multitude of different experiments to be performed.
To determine if these replicons are functional in mosquito cells
and to characterize their kinetics with regards to the expression of
the reporter proteins, Aag2 cells were transfected with in vitro
transcribed capped CHIKVRep(3F)RLuc-SG-FFLuc, lysed at
Innate Immunity in CHIKV-Infected Mosquitoes
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different time points post transfection (24, 48 and 72 hours post
transfection; hpt) and luciferase expression determined. Luciferase
expression (both FFLuc [data not shown] and RLuc) can be
measured by 24 hpt with a peak at 48 hpt and a slight decrease at
72 hpt (Fig. 1B). These time points were chosen to allow sufficient
time for replicon replication but also taking into consideration the
transient nature of transfections. These data suggest that the
engineered replicons are replicating in Aag2 cells.
The RNAi pathway has been identified as being the major
antiviral pathway in control of replication of a number of
arboviruses in mosquitoes [4,5]. The generally accepted method
of confirming antiviral activity in mosquito cell culture and
mosquitoes is RNAi mediated knockdown of components of
individual small RNA pathways [3,18,19,37]. Therefore, in order
to determine whether the exogenous RNAi pathway also limits
CHIKV replication in Aag2 cells, unique dsRNAs were designed
and validated against the exogenous RNAi pathway component
Ago-2 and the miRNA pathway component Ago-1 [4,5].
Knockdown was determined by quantitative RT-PCR (Fig. 2A).
Having shown efficient knockdown of both Ago-1 and Ago-2 (42%
or 25% respectively), their contribution in control of CHIKV
replication was assessed. Aag2 cells were transfected with dsRNA
(Ago-1 and Ago-2 specific or eGFP-specific as a control), followed
by transfection of in vitro transcribed capped CHIKVRep(3F)R-
Luc-SG-FFLuc and lysed after 24 hpt of replicon. A significant
(Student’s t-test; p = 0.045) 9-fold increase in RLuc expression was
observed in cells treated with Ago-2 specific dsRNA compared to
cells with control dsRNA. In contrast, no significant increase in
RLuc expression was observed for cells transfected with Ago-1
specific dsRNA (Fig. 2B). These data suggest that the miRNA
pathway is not involved in the inhibition of CHIKV replication in
Ae. aegypti-derived cells, in contrast to the exogenous RNAi
response that is able to inhibit CHIKV replication in vitro.
Effects of Ago-2 dsRNA injection on CHIKV infection and
dissemination in Ae. aegypti
Having shown an inhibitory effect of the exogenous RNAi
pathway on CHIKV replication in mosquito cells, similar
experiments were performed in mosquitoes to determine if Ae.
aegypti RNAi components are required for defence against
CHIKV in vivo.
First, CHIKV infection kinetics was determined in Ae. aegypti
mosquitoes, infected with bloodmeals containing different virus
titers, by subsequent determination of dissemination rates by IFA
on head squashes at several time points (Fig. 3). Maximum
dissemination was observed at day 7 post infection (pi) with 52%
for a blood-meal titer of 106 PFU/ml, at day 6 pi (100%) for
107 PFU/ml, and at day 3 pi (100%) for 108 PFU/ml. Based on
these patterns, the intermediate titer of 107 PFU/ml was chosen
for further assays on RNAi-based gene-silencing. Gene silencing
Figure 1. Replication of CHIKVRep(3F)RLuc-SG-FFLuc in Aag2 cells. (A) Schematic representation of CHIKV replicons. RLuc was inserted into
the C-terminal region of the nsP3 protein and sequence encoding for FFLuc was cloned in place of the structural open reading frame under the
control of the subgenomic promoter to give CHIKVRep(3F)RLuc-SG-FFLuc. A second replicon with no reporter in the non-structural open reading
frame and coding sequence of eGFP cloned under control of the subgenomic promoter was created, CHIKVRep-SG-eGFP. (B) Aag2 cells were
transfected with in vitro transcribed CHIKVRep(3F)RLuc-SG-FFLuc RNA and RLuc activity measured 24, 48 or 72 h post transfection (hpt). Graph shows
the mean RLuc readings from a representative single experiment carried out in triplicate. Error bars show the standard error of mean. Three
independent experiments have been carried out in triplicate.
doi:10.1371/journal.pntd.0002994.g001
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efficiency was then tested. 500 ng dsRNA (Ago-2 specific or
FFLuc specific as a control) was injected into mosquitoes 48 h
prior to infectious blood-meal (CHIKV at 107 PFU/ml). Ago-2
expression (relative to S7 expression) in midguts or heads of
injected mosquitoes was determined by real-time quantitative
PCR at time points indicated (1, 2, 3, 4 and 7 days pi). The S7
gene was chosen as a control housekeeping gene due to its stability
in infected and non-infected conditions [data not shown].
Mosquitoes were analyzed at days 0, 1, 2, 3, 4 and 7 pi. Injection
of Ago-2 specific dsRNA strongly decreased the expression of Ago-
2 in midguts (Fig. 4A: ranging from 80% silencing at day 2 to 70%
silencing at day 7) and heads (Fig. 4C: ranging from 68% at day 2
to 50% at day 7) compared to the controls (FFLuc specific dsRNA
dsFFLuc, PBS or non-injected mosquitoes). Silencing was effective
from day 2 up to 7 pi.
To test whether silencing of Ago-2 expression would increase
CHIKV replication in Ae. aegypti following an infectious blood-
meal, midguts and heads of the previous experiments were examined
for CHIKV production. The number of infectious viral particles was
determined by plaque assay of midguts and heads of 10 females at
day 1, 2, 3, 4, and 7 pi (Fig. 4 B and D). A non-significant increase of
virus in midguts was observed between mosquitoes injected with
Ago-2 specific dsRNA and controls (dsFFLuc, PBS and non-injected)
at day 1, 2 and 3 pi (Kruskall-Wallis Test: p.0.05). However, at day
4 and 7 pi a significant increase in the number of virus particles in
midguts was detected following Ago-2 knockdown (Kruskall-Wallis
test: p,0.05) (Fig. 4B). To determine the effect of gene silencing on
viral dissemination, the number of viral particles in heads was also
determined. At day 4 pi, heads of mosquitoes injected with Ago-2-
specific dsRNA contained significantly more infectious viral particles
(103.16102.3) (Fig. 4D) than controls (Kruskall-Wallis test: p,0.05).
This effect was transitory as at day 7 pi, viral loads remained similar
when compared to other treatments. Taken together the in vitro and
in vivo data imply a control of virus replication by the exogenous
RNAi pathway with the virus being unable or not efficiently able to
avoid this antiviral response.
Viral inhibition of innate immune pathways
Similar to other arboviruses, CHIKV may have evolved
mechanisms which allow the virus to evade or suppress the
induction of innate immune signaling pathways [6]. To investigate
this possibility, signaling assays were performed in Aag2 cells
similar to those described previously [23]. First, inhibition of
innate immune pathways by CHIKV RNA was determined. Gene
expression studies have shown the presence of JAK/STAT, IMD
and Toll in Aag2 cells, which make them suitable models for the
subsequent experiments [26,29]. Preliminary experiments indicat-
ed the suitability of reporter gene expression studies and bacterial
stimulation to study these pathways also in our Aag2 cells [not
shown]. Therefore, Aag2 cells were co-transfected with in vitro
transcribed capped CHIKVRep-SG-eGFP (not expressing lucif-
erase) and plasmids encoding FFLuc under control of promoters
that are activated in response to immune signaling of the JAK/
Figure 2. Knockdown of Ago-1 and Ago-2 in Aag2 cells and
effect on CHIKV replication in Aag2 cells. (A) Ae. aegypti-derived
Aag2 cells were transfected with 500 ng dsRNA and target transcripts
analysed by qRT-PCR. Graph shows the relative transcript expression
relative to eGFP-specific dsRNA treated cells and normalised to S7. Error
bars show standard error of mean. (B) Aag2 cells were transfected with
500 ng of indicated dsRNAs, followed by transfection of in vitro
transcribed CHIKVRep(3F)RLuc-SG-FFLuc replicon RNA and RLuc levels
were measured. Graph shows mean RLuc levels from three independent
experiments performed in triplicate. Error bars show the standard error
of mean. *, Student’s t-test, p = 0.045.
doi:10.1371/journal.pntd.0002994.g002
Figure 3. CHIKV infection in Ae. aegypti. Disseminated infection
rates (DIR) were determined by estimating the proportion of
mosquitoes with disseminated infection (where infection has spread
beyond the midgut and led to infection of secondary organs including
the salivary glands) among tested females. Three viral titers were tested:
106, 107 and 108 PFU/ml.
doi:10.1371/journal.pntd.0002994.g003
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STAT (p662DRAF-Luc), IMD (pJL195) and Toll (pJM648)
pathways and an internal transfection control plasmid pAct-
Renilla. This was followed by stimulation of the different pathways
by either heat inactivated E. coli or B. subtilis and expression of
FFLuc and RLuc was detected. Stimulated cells without CHIKV
replicon showed a significant increase in FFLuc expression in case
of E. coli or B. subtilis respectively for both JAK/STAT, IMD and
Toll stimulations (Fig. 5 A–C control versus E. coli or B. subtilis
[p =,0.001]). Cells co-transfected with the CHIKV RNA and
pathway specific constructs, showed a much reduced level of
stimulation compared to cells lacking the CHIKV replicon after
IMD stimulation and a highly significant reduction in the level of
stimulation after JAK/STAT and Toll stimulation (2.5 fold less
JAK/STAT stimulation, 3.4 fold less IMD stimulation and 4.9
fold less Toll pathway stimulation in the presence of CHIKV)
(Fig. 5 A–C control versus CHIKV+E. coli or CHIKV+B. subtilis
[p =,0.001]). However, presence of the CHIKV replicon RNA
also significantly reduced RLuc expression, regardless of which
pathway was tested, compared to cells lacking the CHIKV
replicon (Fig. 5 A–C control vs CHIKV [p=,0.001]). Moreover,
inclusion of the CHIKV replicon RNA reduced the RLuc
expression levels without stimulation of other pathways (Fig. 5
A–C control versus CHIKV [p=,0.001]). The reduction in
RLuc expression is specifically due to the presence of the CHIKV
replicon as co-transfection of pACT-Renilla plasmid and a control
luciferase RNA expressing FFLuc did not result in a reduction of
RLuc expression (Fig. 5D). These data suggest that, similar to
findings for the related alphavirus SFV [23], CHIKV can shut
down, albeit incompletely, the host cell transcription/translation
systems and this general targeting mechanism also interferes with
immune pathway stimulation, especially with regards to the Toll
pathway which cannot be stimulated in the presence of CHIKV.
In order to determine on which cellular process CHIKV is
exerting its effect, CHIKV replicon RNA was co-transfected with
control FFLuc expressing RNA and the translation of FFLuc
assessed by luciferase assay. While there is a small reduction in
FFLuc expression upon co-transfection of CHIKVRep-SG-eGFP
replicon, there is not the same significant effect on the control
RNA in the presence of CHIKV (Fig. 5E) as there is during the co-
transfection with the pACT-Renilla plasmid. Therefore, similar to
the related SINV and SFV, it is likely that CHIKV host cell shut-
off occurs at a transcriptional level [41–43]. It should be noted that
this incomplete or weak shut-off does not appear to have the
detrimental effects often observed in alphavirus-infected vertebrate
cells, but nonetheless affects host cell signaling.
Control of CHIKV replication by JAK/STAT, IMD and Toll
signaling pathways
As CHIKV was shown to inhibit immune signaling via host
cell shut off, we hypothesized these pathways could induce
antiviral activities. In order to investigate these possibilities, Aag2
cells were stimulated with either heat inactivated E. coli (to
induce JAK/STAT and IMD signaling) or B. subtilis (to induce
Toll signaling) prior to transfection of in vitro transcribed and
capped CHIKVRep(3F)RLuc-SG-FFLuc. Replication was de-
termined by measuring by FFLuc expression (Fig. 6). Stimulation
of cells prior to replicon transfection had no effect on CHIKV
replication regardless of whether cells were stimulated with gram
negative or gram positive bacteria. This suggests the Toll, IMD
and JAK/STAT pathways cannot affect CHIKV replicon
replication.
Discussion
Innate immune responses are important for regulating arboviral
replication in mosquitoes. The JAK/STAT, IMD and Toll
immune signaling pathways have been individually implicated in
the control of arbovirus replication in mosquitoes in a virus/
pathway-dependent manner [20,21,23,25]. In addition, the
exogenous RNAi pathway is a key mosquito antiviral pathway
[4,5]. The re-emerging CHIKV is known to induce an RNAi
response in infected mosquitoes [12]. CHIKV infection of
mosquitoes and their derived cell lines results in the production
of small RNAs indicating that small RNA pathways are activate
against CHIKV and that the presence of an RNAi inhibitor
resulted in increased virus replication and virus production [12].
This study, however, did not identify which small RNA pathways
have antiviral activity. Expression of the RNAi inhibitor B2 by
CHIKV affected both exogenous RNAi and piRNA pathways
thus making it unclear which of these pathways affected viral
replication. Indeed, our study identifies one such pathway
specifically. Here we have demonstrated that Ago-2 plays an
important role in the antiviral RNAi response to CHIKV both in
vitro and in vivo, and that the induced exogenous RNAi response
mediates effective antiviral activities. The exogenous RNAi
pathway has previously been shown to mediate antiviral activities
against three other alphaviruses, SINV, SFV and ONNV
[18,19,37]. In the case of CHIKV infection, production of small
RNAs produced by the exogenous RNAi and piRNA pathways
has also been demonstrated [12] and our data demonstrate that
the exogenous RNAi does indeed mediate antiviral activity. In the
case of SINV infection of Ae. aegypti mosquitoes, knockdown of
Ago-2 resulted in a transient increase in virus replication and titer
early in infection; however, similar to our findings, the effect was
lost by day 7 [18]. Additionally, engineering the Flock House
Virus RNAi inhibitor B2 protein into SINV increased the
mortality rate, indicating that RNAi is vital in controlling virus
replication to levels that are non-pathogenic to the arthropod
vector [44]. A similar effect was reported for exogenous RNAi
control of DENV replication in Ae. aegypti [3]. Our results extend
the importance of the exogenous RNAi pathway to another virus
of medical importance, CHIKV. Knockdown results for Ago-2
directly show that CHIKV replication is inhibited by the RNAi
pathway and that the small RNAs produced in the exogenous
RNAi pathway do mediate antiviral activity. It has been postulated
that arboviruses may in fact subject themselves to RNAi control to
ensure vector survival, which may explain why no RNA silencing
suppressor (RSS) proteins have been identified to date in
arboviruses. Recently, an RSS was found in the flaviviruses
DENV and WNV. The RSS was not a viral protein but a highly
structured region in the 39 UTR of the flavivirus genome called
subgenomic flavivirus RNA (sfRNA) which is proposed to act as an
Figure 4. Infectious viral particles in midguts and heads of Ae. aegyptimosquitoes injected with Ago-2-specific dsRNA and infected
with CHIKV. Two days after injection of 500 ng dsRNAs, mosquitoes were orally infected with a blood-meal at a titer of 107 PFU/ml. The expression
of Ago-2 in midguts (A) and heads (C) was calculated relative to the expression of internal control S7 gene at each day post infection (pi) by real-time
quantitative PCR. At indicated days pi, PFUs as measure of virus replication were determined by plaque assay of (B) midguts and (D) heads. 10
individuals were analyzed at each day pi. Controls were FFluc-specific dsRNA-injected, PBS-injected and non-injected (NINJ) mosquitoes. Bars indicate
standard deviations. Significance (*) was determined by using Kruskall-Wallis test (p,0.05).
doi:10.1371/journal.pntd.0002994.g004
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Figure 5. CHIKV inhibition of JAK/STAT, IMD and Toll signaling pathways. Signaling assays were performed as previously described [23].
Aag2 cells were co-transfected with reporter plasmids and in vitro transcribed CHIKVRep-SG-eGFP RNA, followed by stimulation of immune pathways
by heat inactivated bacteria. Signaling activity was measured by activity of FFluc. Internal transfection control (RLuc) is shown to indicate the levels of
gene expression. PBS, PBS added to cells containing only the pathway reporter and internal transfection control; E. coli, heat inactivated bacteria
added to cells containing only the pathway reporter and internal transfection control; B. subtilis, heat inactivated bacteria added to cells containing
only the pathway reporter and internal transfection control; CHIKV, PBS added to cells containing pathway reporter, internal transfection control and
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RNAi inhibitor [28]. It is yet to be seen if a similar mechanism is
employed by alphaviruses to escape replication control by RNAi
although an evasion mechanism has been suggested for SFV [11].
Antiviral responses other than RNAi in mosquitoes are
beginning to emerge, and these innate immune pathways play a
vital role in antiviral defence in a virus dependent manner. We
have identified that in particular the Toll immune signaling
pathway is strongly inhibited by CHIKV in vitro, most likely by
a mechanism involving host shut-off. The JAK/STAT and IMD
pathways have previously been reported to be involved in anti-
viral defense against SINV in Drosophila [24,25]. On the other
hand, gene array studies suggested inhibition of Toll signaling
late in infection and possibly activation of IMD signaling in
SINV-infected Ae. aegypti mosquitoes [45]. However, in Aag2
cells infected with SINV gene expression studies revealed no
activation of these pathways (with the exception of weak
upregulation of STAT itself) [26]. The design of these
experiments with SINV makes it difficult to come to any
conclusion with regards to viral inhibition, but recent work has
shown that SFV as well as DENV have been able to inhibit
innate immune signaling in mosquito cells [23,29]. Despite this,
IMD and/or JAK/STAT but not Toll can mediate antiviral
activity against SFV, while Toll and JAK/STAT induce antiviral
responses against DENV [20,21,23]. We found no effect of any
of these pathways on CHIKV replicon replication either because
they do not act antivirally or because viral inhibition of any
antiviral effects is strong enough to mask these. This points to
virus specific differences or highly efficient inhibition of the
immune pathways by CHIKV. Interestingly, only a minor
activity by the IMD pathway was shown against ONNV [27],
which is closely related to CHIKV therefore these viruses may
respond in a more similar manner. Overall, this interplay
between antiviral signaling and viral inhibition is strongly
reminiscent of viral interactions with the innate immune
responses, such as the interferon system of vertebrate cells [46–
48]. At least for SFV, and our observations with CHIKV, shut
off of host gene expression appears to mediate signaling
inhibition in mosquito cells, as it does in vertebrate cells [23].
The mechanism by which shut-off occurs is not clear, although
our data (Fig. 5E) suggest an effect prior to translation, possibly
at the transcriptional level as occurs in vertebrate cells [41–43].
We cannot rule out competition between host and viral mRNAs,
differences in mRNA stability or other processes that would lead
to differences in translation, however, as reporter mRNAs are
not affected by CHIKV replicon this appears unlikely. Other
inhibitory strategies employed by arboviruses may also resemble
those used in vertebrate cells. In the presence of RNAi, virus
replication may still be controlled to a non-harmful level. Recent
work has indicated candidates for antimicrobial peptides, attC
and dptB, that inhibit SINV replication in Drosophila [24].
Similar mechanisms in mosquito cells remain to be determined.
Clearly, there is no direct effect of these classical immune
signaling pathways on CHIKV replication under our experi-
mental conditions.
In conclusion, we demonstrated that the exogenous RNAi
pathway plays a vital role in limiting CHIKV replication in cell
culture and in mosquitoes. Knockdown of Ago-2 resulted in a
significant increase in RNA replication and virus titers. Addition-
ally, we have shown that CHIKV significantly represses Toll
pathway stimulation, and stimulation of major insect immune
pathways did not limit CHIKV replication. This indicates that
antiviral immunity is a complex process which needs more
research to tease out the complexities of the virus/host interactions
and differences exist even between closely related alphaviruses.
Exogenous RNAi is also active against CHIKV while analysis of
immune signaling pathways indicates differences to other arbovi-
ruses including other alphaviruses. Taken together this and other
studies suggest that the RNAi response is the most generally active
antiviral pathway in mosquitoes.
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CHIKVRep-SG-eGFP replicon RNA; CHIKV+E. coli, heat inactivated E. coli added to cells containing pathway reporter, internal transfection control and
CHIKVRep-SG-eGFP replicon; CHIKV+B. subtilis, heat inactivated B. subtilis added to cells containing pathway reporter, internal transfection control
and CHIKVRep-SG-eGFP replicon. Data is shown after subtraction of background luciferase levels and relative to PBS control. (A) JAK/STAT pathway
stimulation with heat inactivated E. coli in the presence or absence of CHIKV replicon. (B) IMD pathway stimulation with heat inactivated E. coli in the
presence or absence of CHIKV replicon. (C) Toll pathway stimulation with heat inactivated B. subtilis in the presence or absence of CHIKV replicon. (D)
Co-transfection of pACT-Renilla with either CHIKVRep-SG-eGFP replicon RNA or control FFLuc expressing RNA. (E) Co-transfection of control RNA in
the presence and absence of CHIKVRep-SG-eGFP replicon RNA. Graphs represent the mean of three independent experiments performed in triplicate
and error bars represent the standard error of mean. *, significantly different using a general linear mixed model.
doi:10.1371/journal.pntd.0002994.g005
Figure 6. Effects of pathway stimulation on CHIKVRep(3F)RLuc-
SG-FFLuc replication. Aag2 cells were pre-stimulated with heat
inactivated bacteria, followed by transfection of CHIKVRep(3F)RLuc-SG-
FFLuc replicon RNA. Replicon replication was assessed 12 h post
pathway stimulation by FFLuc activity. PBS, PBS added to cells
containing CHIKVRep(3F)RLuc-SG-FFLuc replicon; E. coli, heat inactivat-
ed bacteria added to cells containing CHIKVRep(3F)RLuc-SG-FFLuc
replicon; B. subtilis, heat inactivated bacteria added to cells containing
CHIKVRep(3F)RLuc-SG-FFLuc replicon. The dark grey bar shows
CHIKVRep(3F)RLuc-SG-FFLuc replication after JAK/STAT and IMD
pathway stimulation with heat inactivated E. coli. Light grey bar shows
CHIKVRep(3F)RLuc-SG-FFLuc replication after Toll pathway stimulation
with heat inactivated B. subtilis. Replicon replication after bacterial
stimulation is calculated relative to replicon replication after stimulation
with PBS (black bar). The graph represents the mean of three
independent experiments performed in triplicate and error bars
represent the standard error of mean.
doi:10.1371/journal.pntd.0002994.g006
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